- Dual Mechanism of Action: Lorvas SR 1.5 mg Tablet combines diuretic and direct vasodilatory properties for effective and sustained blood pressure reduction.
- Metabolically Neutral: The formulation has a more favorable effect on glucose and lipid metabolism compared to conventional thiazide diuretics.
- Sustained Once-Daily Action: Lorvas SR 1.5 mg Tablet supports consistent 24-hour blood pressure control due to its lipophilicity and protein binding.
- Cardiovascular Risk Reduction: Well-established evidence supports its role in reducing stroke and cardiovascular events in hypertensive patients.
- Well Tolerated at Low Doses: Lower doses of Lorvas SR 1.5 mg Tablet provide effective antihypertensive action with reduced risk of electrolyte disturbance.
- Effective Management of Hypertension: Lorvas SR 1.5 mg Tablet is primarily used to manage high blood pressure effectively.
- Reduction of Oedema: This medication is also beneficial in treating oedema associated with heart failure.
- Improved Quality of Life: Patients using Lorvas SR 1.5 mg Tablet often experience an enhanced quality of life due to better blood pressure control.
Lorvas SR 1.5 mg Tablet - Strip of 10
Compositions : Indapamide 1.5mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Torrent Pharmaceuticals Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Lorvas SR 1.5 mg Tablet is a pharmaceutical formulation that contains indapamide, a sulphonamide-derived thiazide-like diuretic. This unique medication is distinguished by its dual action, combining both diuretic and direct vascular effects, setting it apart from conventional thiazide diuretics. The primary purpose of Lorvas SR 1.5 mg Tablet is to manage hypertension effectively while minimizing the risk of fluid and electrolyte disturbances. The key composition of Lorvas SR 1.5 mg Tablet includes indapamide, which works by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys. This action reduces sodium and water reabsorption, leading to increased urinary output and a decrease in plasma volume, which ultimately contributes to lowering blood pressure. Additionally, Lorvas SR 1.5 mg Tablet exerts a direct vasodilatory effect on vascular smooth muscle by blocking calcium influx, thereby reducing vascular reactivity to pressor agents such as noradrenaline and angiotensin II. At lower doses, this vasodilatory mechanism predominates over the diuretic effect, providing sustained blood pressure control with minimal fluid and electrolyte disturbance compared to higher-dose thiazide therapy. The lipophilic nature of indapamide allows for extensive binding to plasma proteins and vascular smooth muscle, resulting in a prolonged duration of action suitable for once-daily dosing. Furthermore, Lorvas SR 1.5 mg Tablet has favorable metabolic properties, exhibiting a more neutral effect on glucose and lipid metabolism than conventional thiazide diuretics. This makes Lorvas SR 1.5 mg Tablet an ideal choice for patients requiring long-term management of hypertension without significant metabolic side effects. Overall, Lorvas SR 1.5 mg Tablet is a well-tolerated and effective option for individuals seeking to control their blood pressure while minimizing potential complications associated with mineral deficiencies and electrolyte imbalances.
Product Details
Lorvas SR 1.5 mg Tablet functions as a thiazide diuretic that lowers blood pressure by removing excess water and certain electrolytes from the body while also relaxing blood vessels to improve blood flow.
- Indapamide inhibits sodium reabsorption in the distal convoluted tubule, leading to increased urinary output.
- The reduction in plasma volume contributes to lower cardiac preload, effectively decreasing blood pressure.
- Direct vasodilatory effects are achieved by blocking calcium influx into vascular smooth muscle.
- This dual mechanism allows for sustained blood pressure control with minimal fluid retention.
- Lower doses of Lorvas SR 1.5 mg Tablet primarily exert vasodilatory effects rather than diuretic effects.
- The medication is lipophilic, allowing for prolonged action suitable for once-daily dosing.
- Indapamide's favorable metabolic profile makes it a preferred choice for hypertensive patients with metabolic concerns.
- Use Lorvas SR 1.5 mg Tablet exactly as prescribed by your healthcare provider.
- The medication is typically taken orally once daily, preferably in the morning to avoid nocturnal diuresis.
- For consistent blood pressure control, take Lorvas SR 1.5 mg Tablet at the same time each day.
- Swallow the tablets whole unless instructed otherwise by your doctor.
- Do not discontinue use without consulting your healthcare provider first.
- The usual recommended dosage is between 1.5 mg to 2.5 mg once daily in the morning, depending on individual health needs.
- Consult your doctor for any adjustments in dosage based on your specific condition or response to treatment.
- Regular monitoring of blood pressure and electrolytes is advised during treatment with Lorvas SR 1.5 mg Tablet.
- Take Lorvas SR 1.5 mg Tablet in the morning to minimize nocturnal urination that could disrupt sleep.
- Regularly monitor electrolyte levels through periodic blood tests during long-term treatment with this medication.
- Rise slowly from sitting or lying positions to prevent postural hypotension during early treatment or after dose adjustments.
- Maintain adequate fluid intake; avoid excessive fluid restriction that could exacerbate electrolyte disturbances caused by diuresis.
- Inform your healthcare provider about all medications being taken, as several drugs can interact with Lorvas SR 1.5 mg Tablet affecting electrolyte balance or blood pressure control.
Safety Advice
Side Effects
- Common side effects include hypokalaemia (low potassium levels), which may require monitoring during treatment with Lorvas SR 1.5 mg Tablet.
- Dizziness or light-headedness may occur, especially upon standing due to blood pressure reduction.
- Increased urination is expected as a result of the diuretic action of Lorvas SR 1.5 mg Tablet.
- Mild headaches may develop during the initial stages of treatment with this medication.
- Uncommon side effects may include hyponatraemia (low sodium levels), particularly in elderly patients.
- Muscle cramps can occur due to electrolyte disturbances associated with Lorvas SR 1.5 mg Tablet.
- Nausea or mild gastrointestinal discomfort may be experienced by some individuals taking this medication.
- Serious side effects requiring immediate medical attention include severe electrolyte disturbances, QT interval prolongation, severe allergic reactions, and acute renal impairment.
Precautions and Warnings
- Patients with known allergies to sulphonamides or thiazide diuretics should inform their doctor before using Lorvas SR 1.5 mg Tablet due to potential cross-sensitivity.
- This medication is not recommended during pregnancy due to risks associated with fetal electrolyte disturbance and reduced placental perfusion.
- Breastfeeding mothers should consult their healthcare provider before using Lorvas SR 1.5 mg Tablet as it may not be safe during lactation.
- Caution is advised when driving or operating machinery as dizziness may impair alertness during early treatment.
- Avoid alcohol consumption while taking Lorvas SR 1.5 mg Tablet as it may enhance hypotension and dizziness risks.
- Patients with liver or kidney impairment should use Lorvas SR 1.5 mg Tablet cautiously, as electrolyte disturbances may worsen these conditions.
- Elderly patients are at increased risk for hypotension and electrolyte imbalances; close monitoring is essential during treatment with this medication.
FAQs
Lorvas SR 1.5mg Tablet is primarily used for managing hypertension and treating oedema associated with heart failure.
2. How does Lorvas SR 1.5mg Tablet work?
The active ingredient indapamide inhibits sodium reabsorption in the kidneys while also relaxing blood vessels, leading to effective blood pressure reduction.
3. How is indapamide different from conventional thiazide diuretics?
Indapamide has a unique direct vasodilatory mechanism that provides blood pressure reduction even at lower doses with minimal diuretic effect.
4. When should Lorvas SR 1.5mg Tablet be taken?
It is recommended to take Lorvas SR 1.5mg Tablet in the morning to ensure effective management of blood pressure throughout the day.
5. Can Lorvas SR 1.5mg Tablet cause low potassium?
Yes, hypokalaemia can occur due to increased potassium excretion; regular monitoring of potassium levels is advisable.
6. Is Lorvas SR 1.5mg Tablet safe for diabetic patients?
Indapamide is generally considered safe for diabetic patients due to its favorable metabolic profile compared to traditional thiazides.
7. Can Lorvas SR 1.5mg Tablet be used in elderly patients?
Yes, it is effective for elderly patients but requires careful monitoring for potential side effects like hypotension.
Instructions
Directions for Use
Storage and Disposal
- Store below 25°C
- Keep in a dry place, away from light and moisture
- Keep out of reach of children
- Dispose of unused medicine as per local regulations
More Information
| SKU | 432035 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Lorvas SR 1.5 mg Tablet is a pharmaceutical formulation that contains indapamide, a sulphonamide-derived thiazide-like diuretic. This unique medication is distinguished by its dual action, combining both diuretic and direct vascular effects, setting it apart from conventional thiazide diuretics. The primary purpose of Lorvas SR 1.5 mg Tablet is to manage hypertension effectively while minimizing the risk of fluid and electrolyte disturbances. The key composition of Lorvas SR 1.5 mg Tablet includes indapamide, which works by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys. This action reduces sodium and water reabsorption, leading to increased urinary output and a decrease in plasma volume, which ultimately contributes to lowering blood pressure. Additionally, Lorvas SR 1.5 mg Tablet exerts a direct vasodilatory effect on vascular smooth muscle by blocking calcium influx, thereby reducing vascular reactivity to pressor agents such as noradrenaline and angiotensin II. At lower doses, this vasodilatory mechanism predominates over the diuretic effect, providing sustained blood pressure control with minimal fluid and electrolyte disturbance compared to higher-dose thiazide therapy. The lipophilic nature of indapamide allows for extensive binding to plasma proteins and vascular smooth muscle, resulting in a prolonged duration of action suitable for once-daily dosing. Furthermore, Lorvas SR 1.5 mg Tablet has favorable metabolic properties, exhibiting a more neutral effect on glucose and lipid metabolism than conventional thiazide diuretics. This makes Lorvas SR 1.5 mg Tablet an ideal choice for patients requiring long-term management of hypertension without significant metabolic side effects. Overall, Lorvas SR 1.5 mg Tablet is a well-tolerated and effective option for individuals seeking to control their blood pressure while minimizing potential complications associated with mineral deficiencies and electrolyte imbalances.
- Dual Mechanism of Action: Lorvas SR 1.5 mg Tablet combines diuretic and direct vasodilatory properties for effective and sustained blood pressure reduction.
- Metabolically Neutral: The formulation has a more favorable effect on glucose and lipid metabolism compared to conventional thiazide diuretics.
- Sustained Once-Daily Action: Lorvas SR 1.5 mg Tablet supports consistent 24-hour blood pressure control due to its lipophilicity and protein binding.
- Cardiovascular Risk Reduction: Well-established evidence supports its role in reducing stroke and cardiovascular events in hypertensive patients.
- Well Tolerated at Low Doses: Lower doses of Lorvas SR 1.5 mg Tablet provide effective antihypertensive action with reduced risk of electrolyte disturbance.
- Effective Management of Hypertension: Lorvas SR 1.5 mg Tablet is primarily used to manage high blood pressure effectively.
- Reduction of Oedema: This medication is also beneficial in treating oedema associated with heart failure.
- Improved Quality of Life: Patients using Lorvas SR 1.5 mg Tablet often experience an enhanced quality of life due to better blood pressure control.
Lorvas SR 1.5 mg Tablet functions as a thiazide diuretic that lowers blood pressure by removing excess water and certain electrolytes from the body while also relaxing blood vessels to improve blood flow.
- Indapamide inhibits sodium reabsorption in the distal convoluted tubule, leading to increased urinary output.
- The reduction in plasma volume contributes to lower cardiac preload, effectively decreasing blood pressure.
- Direct vasodilatory effects are achieved by blocking calcium influx into vascular smooth muscle.
- This dual mechanism allows for sustained blood pressure control with minimal fluid retention.
- Lower doses of Lorvas SR 1.5 mg Tablet primarily exert vasodilatory effects rather than diuretic effects.
- The medication is lipophilic, allowing for prolonged action suitable for once-daily dosing.
- Indapamide's favorable metabolic profile makes it a preferred choice for hypertensive patients with metabolic concerns.
- Use Lorvas SR 1.5 mg Tablet exactly as prescribed by your healthcare provider.
- The medication is typically taken orally once daily, preferably in the morning to avoid nocturnal diuresis.
- For consistent blood pressure control, take Lorvas SR 1.5 mg Tablet at the same time each day.
- Swallow the tablets whole unless instructed otherwise by your doctor.
- Do not discontinue use without consulting your healthcare provider first.
- The usual recommended dosage is between 1.5 mg to 2.5 mg once daily in the morning, depending on individual health needs.
- Consult your doctor for any adjustments in dosage based on your specific condition or response to treatment.
- Regular monitoring of blood pressure and electrolytes is advised during treatment with Lorvas SR 1.5 mg Tablet.
- Take Lorvas SR 1.5 mg Tablet in the morning to minimize nocturnal urination that could disrupt sleep.
- Regularly monitor electrolyte levels through periodic blood tests during long-term treatment with this medication.
- Rise slowly from sitting or lying positions to prevent postural hypotension during early treatment or after dose adjustments.
- Maintain adequate fluid intake; avoid excessive fluid restriction that could exacerbate electrolyte disturbances caused by diuresis.
- Inform your healthcare provider about all medications being taken, as several drugs can interact with Lorvas SR 1.5 mg Tablet affecting electrolyte balance or blood pressure control.
Side Effects
- Common side effects include hypokalaemia (low potassium levels), which may require monitoring during treatment with Lorvas SR 1.5 mg Tablet.
- Dizziness or light-headedness may occur, especially upon standing due to blood pressure reduction.
- Increased urination is expected as a result of the diuretic action of Lorvas SR 1.5 mg Tablet.
- Mild headaches may develop during the initial stages of treatment with this medication.
- Uncommon side effects may include hyponatraemia (low sodium levels), particularly in elderly patients.
- Muscle cramps can occur due to electrolyte disturbances associated with Lorvas SR 1.5 mg Tablet.
- Nausea or mild gastrointestinal discomfort may be experienced by some individuals taking this medication.
- Serious side effects requiring immediate medical attention include severe electrolyte disturbances, QT interval prolongation, severe allergic reactions, and acute renal impairment.
Precautions and Warnings
- Patients with known allergies to sulphonamides or thiazide diuretics should inform their doctor before using Lorvas SR 1.5 mg Tablet due to potential cross-sensitivity.
- This medication is not recommended during pregnancy due to risks associated with fetal electrolyte disturbance and reduced placental perfusion.
- Breastfeeding mothers should consult their healthcare provider before using Lorvas SR 1.5 mg Tablet as it may not be safe during lactation.
- Caution is advised when driving or operating machinery as dizziness may impair alertness during early treatment.
- Avoid alcohol consumption while taking Lorvas SR 1.5 mg Tablet as it may enhance hypotension and dizziness risks.
- Patients with liver or kidney impairment should use Lorvas SR 1.5 mg Tablet cautiously, as electrolyte disturbances may worsen these conditions.
- Elderly patients are at increased risk for hypotension and electrolyte imbalances; close monitoring is essential during treatment with this medication.
Lorvas SR 1.5mg Tablet is primarily used for managing hypertension and treating oedema associated with heart failure.
2. How does Lorvas SR 1.5mg Tablet work?
The active ingredient indapamide inhibits sodium reabsorption in the kidneys while also relaxing blood vessels, leading to effective blood pressure reduction.
3. How is indapamide different from conventional thiazide diuretics?
Indapamide has a unique direct vasodilatory mechanism that provides blood pressure reduction even at lower doses with minimal diuretic effect.
4. When should Lorvas SR 1.5mg Tablet be taken?
It is recommended to take Lorvas SR 1.5mg Tablet in the morning to ensure effective management of blood pressure throughout the day.
5. Can Lorvas SR 1.5mg Tablet cause low potassium?
Yes, hypokalaemia can occur due to increased potassium excretion; regular monitoring of potassium levels is advisable.
6. Is Lorvas SR 1.5mg Tablet safe for diabetic patients?
Indapamide is generally considered safe for diabetic patients due to its favorable metabolic profile compared to traditional thiazides.
7. Can Lorvas SR 1.5mg Tablet be used in elderly patients?
Yes, it is effective for elderly patients but requires careful monitoring for potential side effects like hypotension.
Directions for Use
Storage and Disposal
- Store below 25°C
- Keep in a dry place, away from light and moisture
- Keep out of reach of children
- Dispose of unused medicine as per local regulations
| SKU | 432035 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account